Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: NerdyBot Disallow: / User-agent: * Disallow: /assets/* Disallow: /data/* Disallow: |
Title | OMF | See A Cure for Eye |
Description | Together Let’s SEE A Ocular Melanoma Foundation is one of the leading resource for eye cancer patient education and research |
Keywords | eye cancer, ocular melanoma, choroidal melanoma, MRF |
WebSite | ocularmelanoma.org |
Host IP | 72.32.249.98 |
Location | United States |
Site | Rank |
US$23,736,891
Last updated: 2023-05-13 00:18:06
ocularmelanoma.org has Semrush global rank of 445,901. ocularmelanoma.org has an estimated worth of US$ 23,736,891, based on its estimated Ads revenue. ocularmelanoma.org receives approximately 2,738,872 unique visitors each day. Its web server is located in United States, with IP address 72.32.249.98. According to SiteAdvisor, ocularmelanoma.org is safe to visit. |
Purchase/Sale Value | US$23,736,891 |
Daily Ads Revenue | US$21,911 |
Monthly Ads Revenue | US$657,330 |
Yearly Ads Revenue | US$7,887,952 |
Daily Unique Visitors | 182,592 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
ocularmelanoma.org. | A | 7199 | IP: 72.32.249.98 |
ocularmelanoma.org. | NS | 3600 | NS Record: ns26.domaincontrol.com. |
ocularmelanoma.org. | NS | 3600 | NS Record: ns25.domaincontrol.com. |
ocularmelanoma.org. | MX | 3600 | MX Record: 50 ASPMX3.GOOGLEMAIL.COM. |
ocularmelanoma.org. | MX | 3600 | MX Record: 20 ALT1.ASPMX.L.GOOGLE.COM. |
ocularmelanoma.org. | MX | 3600 | MX Record: 30 ALT2.ASPMX.L.GOOGLE.COM. |
ocularmelanoma.org. | MX | 3600 | MX Record: 10 ASPMX.L.GOOGLE.COM. |
ocularmelanoma.org. | MX | 3600 | MX Record: 40 ASPMX2.GOOGLEMAIL.COM. |
ocularmelanoma.org. | TXT | 3600 | TXT Record: v=spf1 include:_spf.google.com ~all |
ocularmelanoma.org. | TXT | 3600 | TXT Record: google-site-verification=dZmxdeqWlZ5Of6WuKv0vgpMt4NpvZsFaOl2BQVG5Vdk |
ocularmelanoma.org. | TXT | 3600 | TXT Record: google-site-verification=HppR1Kat3azV7_ABTsb9v4r5XLa2FPWXJBupGxIoCmY |
ocularmelanoma.org. | TXT | 3600 | TXT Record: google-site-verification=mGQkfYlT6M8nQWO4KRpWUI8ojaDq58iHycn5M00a7r0 |
DONATE NOW Home About OM Basics of OM Screening & Prevention Understanding Nevi Initial Diagnosis Tumor Characterization Genetic Testing Understanding Prognosis Surveillance Common Terms Treatment Primary Radiation Enucleation / Resection Adjuvant Therapy Targeted Radiation Transarterial Chemotherapy Other Liver Treatments Systemic Treatments Clinical Trials for Metastatic Disease Frontier Metastatic Treatments Diet & Lifestyle Living With OM Patient Resources Travel Assistance Prosthetic Assistance FREE Eye Exam Program EANA Patient Retreats Clinical Trials Other Online Resources About Us Mission and Vision Leadership Scientific Advisory Board About Dr. Allen Community Partners Financials and Non-Profit Info Use of Funds Contact Tributes Donate Research Funding Warrior Fundraising Matching Gifts Gifts of Stock Planned Giving Together Let’s SEE A CURE. Ocular melanoma is a rare cancer of the eye affecting only 6 in 1 million people. OMF is the leading resource for eye cancer research |
HTTP/1.1 200 OK Date: Mon, 20 Dec 2021 07:50:41 GMT Server: Apache Expires: Tue, 21 Dec 2021 07:50:41 GMT Vary: Accept-Encoding Content-Type: text/html; charset=utf-8 |
WHOIS LIMIT EXCEEDED - SEE WWW.PIR.ORG/WHOIS FOR DETAILS |